Sponsored Content |Webinar | Contrast Media Injectors| December 08, 2023

On Jan. 10, 2024, Diagnostic and Interventional Cardiology presented a webinar on "Contrast Management in Modern PCI." 

Dr. Aditya Sharma, MD, MBA, FACC, FSCAI, an interventional cardiologist from Wellspan Health in Central Pennsylvania was the presenter. The webinar is sponsored by ACIST Medical Systems.

In the cardiac cath lab, the use of iodinated contrast in both diagnostic and PCI procedures is commonplace. The effects of iodinated contrast on renal function have been known and researched. However, conversations are ongoing around best practices and standards of care regarding contrast management and treatment for those with higher risk factors, like compromised renal function. Participate in this webinar to gain insight on the topic of contrast-induced kidney injury and how one could approach contrast management in modern PCI with use of the ACIST CVi Contrast Delivery System.

Learning Objectives

  • Understand basic mechanisms of contrast induced kidney injury.
  • Determine incidence of disease along with long term patient and economic implications.
  • Review risk factors determining higher risk populations.
  • Evaluate device strategy in modern era to mitigate risk and promote procedural
  • efficiency and safety.
  • Case review of use of the ACIST CVi Contrast Delivery System in high risk patient. 
Dr. Aditya Sharma
Dr Aditya Sharma

Dr. Sharma is board certified in internal medicine, cardiovascular disease, and interventional cardiology, having completed both residency and fellowship programs at George Washington University - School of Medicine and Hospital. He chose a career in medicine to be able to help others while being able to continuously enrich his skills and apply learned scientific knowledge.

Click here to learn more or register for the webinar.


Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.

Related Content

News | Interventional Radiology

January 9, 2024 — Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ...

Home January 09, 2024
News | Interventional Radiology

February 23, 2023 — Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep ...

Home February 23, 2023
News | Interventional Radiology

August 11, 2022 — Bracco Imaging S.p.A. has announced the renewal of the “Bracco Fellowships” initiative, in partnership ...

Home August 11, 2022
News | Interventional Radiology

May 18, 2022 — XACT Robotics, developer of the world’s first and only comprehensive robotic system for interventional ...

Home May 18, 2022
News | Interventional Radiology

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

Home April 27, 2022
News | Interventional Radiology

March 18, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's TheraSphere Y-90 Glass ...

Home March 18, 2021
Feature | Interventional Radiology | By Katie Caron

A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and ...

Home April 03, 2020
News | Interventional Radiology | Melinda Taschetta-Millane

March 9, 2020 — As the novel coronavirus (COVID-19) slowly spreads across the globe, more industry conferences are ...

Home March 09, 2020
News | Interventional Radiology

February 11, 2020 — An ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR) ...

Home February 11, 2020
Subscribe Now